CANADA LIFE ASSURANCE Co Has $4.20 Million Holdings in Maximus, Inc. (NYSE:MMS)

CANADA LIFE ASSURANCE Co trimmed its holdings in shares of Maximus, Inc. (NYSE:MMS) by 6.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,239 shares of the health services provider’s stock after selling 4,052 shares during the period. CANADA LIFE ASSURANCE Co owned 0.10% of Maximus worth $4,197,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of MMS. Dean Investment Associates LLC increased its stake in shares of Maximus by 58.5% in the fourth quarter. Dean Investment Associates LLC now owns 58,644 shares of the health services provider’s stock valued at $4,378,000 after buying an additional 21,650 shares in the last quarter. Farringdon Capital Ltd. acquired a new stake in Maximus in the 4th quarter valued at about $372,000. Zacks Investment Management bought a new position in shares of Maximus in the fourth quarter worth about $329,000. Marshall Wace LLP raised its stake in shares of Maximus by 1,319.1% in the fourth quarter. Marshall Wace LLP now owns 224,267 shares of the health services provider’s stock worth $16,742,000 after acquiring an additional 208,463 shares during the last quarter. Finally, Ontario Teachers Pension Plan Board lifted its position in shares of Maximus by 76.9% during the fourth quarter. Ontario Teachers Pension Plan Board now owns 40,330 shares of the health services provider’s stock worth $3,011,000 after purchasing an additional 17,538 shares in the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Stock Performance

Maximus stock opened at $68.79 on Friday. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The company’s 50-day moving average is $67.66 and its two-hundred day moving average is $74.77. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The company has a market cap of $3.89 billion, a PE ratio of 14.79 and a beta of 0.68.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Equities analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be issued a $0.30 dividend. The ex-dividend date is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.74%. Maximus’s dividend payout ratio is presently 25.81%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a research report on Thursday, January 2nd. StockNews.com downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th.

Insider Buying and Selling at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of the company’s stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now owns 18,097 shares of the company’s stock, valued at approximately $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.